Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound evaluation of gastric residual volume after ondansetron, metoclopramide, or neostigmine in mechanically ventilated ICU patients
IRCT20190215042716N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in feeding intolerance comparing Ondansetron, Metoclopramide and Neostigmine (3 arms). Primary endpoint: Gastric residual volume on ultrasound. Started Aug 2019; status: completed.
02
Drugs
ondansetronmetoclopramideneostigmine
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on IRCT20190215042716N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190215042716N1.